Capital Advisory Group Advisory Services, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

  • $250 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$73.71 - $87.86 $11,056 - $13,179
-150 Closed
0 $0
Q4 2020

Feb 18, 2021
SELL
$84.4 - $177.39 $12,660 - $26,608
-150 Reduced 50.0%
150 $21,000
Q1 2020

May 18, 2020
BUY
$33.8 - $62.9 $10,140 - $18,870
300 New
300 $13,000
Q4 2019

Feb 14, 2020
SELL
$36.08 - $45.83 $10,824 - $13,749
-300 Closed
0 $0
Q1 2019

May 28, 2020
BUY
$39.87 - $69.36 $11,961 - $20,808
300 New
300 $21,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.1B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email